Evidence map›Paper›PMID 9298995›Full record

ArticleThe Journal of cell biology1997

Tyrosine residue in exon 14 of the cytoplasmic domain of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) regulates ligand binding specificity.

J Famiglietti, J Sun, H M DeLisser, S M Albelda

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis.Clinical science (London, England : 1979) · 2015
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J FamigliettiPulmonary and Critical Care Division, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-4283, USA.
J Sun
H M DeLisser
S M Albelda
University of Pennsylvania · US

Funding

STRUCTURE FUNCTION ANALYSIS OF PECAM 1K14HL003382 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI DELISSER, HORACE M · 1995 to 1999
–
ENDOCAM/PECAM--A NOVEL VASCULAR CELL ADHESION MOLECULER01HL046311 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ALBELDA, STEVEN MARK · 1995 to 1999
–
ENDOCAM/PECAM--A NOVEL VASCULAR CELL ADHESION MOLECULER29HL046311 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ALBELDA, STEVEN MARK · 1991 to 1994
–
NHLBI NIH HHS HL-03382NHLBI NIH HHS HL-46311
6 · The paper itself

Abstract

Platelet/endothelial cell adhesion molecule (PECAM-1) is a cell adhesion molecule of the immunoglobulin superfamily that plays a role in a number of vascular processes including leukocyte transmigration through endothelium. The presence of a specific 19- amino acid exon within the cytoplasmic domain of PECAM-1 regulates the binding specificity of the molecule; specifically, isoforms containing exon 14 mediate heterophilic cell-cell aggregation while those variants missing exon 14 mediate homophilic cell-cell aggregation. To more precisely identify the region of exon 14 responsible for ligand specificity, a series of deletion mutants were created in which smaller regions of exon 14 were removed. After transfection into L cells, they were tested for their ability to mediate aggregation. For heterophilic aggregation to occur, a conserved 5-amino acid region (VYSEI in the murine sequence or VYSEV in the human sequence) in the mid-portion of the exon was required. A final construct, in which this tyrosine was mutated into a phenylalanine, aggregated in a homophilic manner when transfected into L cells. Inhibition of phosphatase activity by exposure of cells expressing wild type or mutant forms of PECAM-1 to sodium orthovanadate resulted in high levels of cytoplasmic tyrosine phosphorylation and led to a switch from heterophilic to homophilic aggregation. Our data thus indicate either loss of this tyrosine from exon 14 or its phosphorylation results in a change in ligand specificity from heterophilic to homophilic binding. Vascular cells could thus determine whether PECAM-1 functions as a heterophilic or homophilic adhesion molecule by processes such as alternative splicing or by regulation of the balance between tyrosine phosphorylation or dephosphorylation. Defining the conditions under which these changes occur will be important in understanding the biology of PECAM-1 in transmigration, angiogenesis, development, and other processes in which this molecule plays a role.

Indexed as

Alternative SplicingAnimalsBinding SitesBlood PlateletsCytoplasmExonsLigandsMiceMutagenesisPhosphorylationPlatelet Endothelial Cell Adhesion Molecule-1Protein BindingProtein Structure, TertiarySensitivity and SpecificityTyrosineVanadatesLigandsPlatelet Endothelial Cell Adhesion Molecule-1TyrosineVanadates

Identifiers

PMID9298995
PMCPMC2132561
OpenAlexW2117001955

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.